521 related articles for article (PubMed ID: 9739939)
21. Skin lesions in Waldenström's macroglobulinaemia. Characterization of the cellular infiltrate.
Bergroth V; Reitamo S; Konttinen YT; Wegelius O
Acta Med Scand; 1981; 209(1-2):129-31. PubMed ID: 6782837
[TBL] [Abstract][Full Text] [Related]
22. Giant kidneys in Waldenström's macroglobulinemia.
Grossman ME; Bia MJ; Goldwein MI; Hill G; Goldberg M
Arch Intern Med; 1977 Nov; 137(11):1613-5. PubMed ID: 411441
[TBL] [Abstract][Full Text] [Related]
23. [Anti-smooth-muscle antibody activity of monoclonal IgM in Waldenström's disease].
Krulik M; Vittecoq D; Abuaf N; Genot JY; Homberg JC; Debray J
Sem Hop; 1983 Jun; 59(23):1737-41. PubMed ID: 6308799
[TBL] [Abstract][Full Text] [Related]
24. Uniform response criteria in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Weber D; Treon SP; Emmanouilides C; Branagan AR; Byrd JC; Bladé J; Kimby E
Semin Oncol; 2003 Apr; 30(2):127-31. PubMed ID: 12720121
[TBL] [Abstract][Full Text] [Related]
25. [Diffuse pulmonary infiltration at the onset of Waldenström's disease].
Devouassoux G; Pison C; Lantejoul S; Brambilla E; Brambilla C
Rev Mal Respir; 1995; 12(3):308-10. PubMed ID: 7638428
[TBL] [Abstract][Full Text] [Related]
26. Immunobullous dermatosis associated with Waldenström macroglobulinaemia treated with rituximab.
Chattopadhyay M; Rytina E; Dada M; Bhogal BS; Groves R; Handfield-Jones S
Clin Exp Dermatol; 2013 Dec; 38(8):866-9. PubMed ID: 23782150
[TBL] [Abstract][Full Text] [Related]
27. [Complete response achieved after rituximab plus CHOP therapy in a patient with rapidly progressing Waldenstrom's macroglobulinemia].
Ise M; Sakai C; Kumagai K
Rinsho Ketsueki; 2009 Jan; 50(1):34-8. PubMed ID: 19225227
[TBL] [Abstract][Full Text] [Related]
28. [Waldenström macroglobulinemia associated with cutaneous lesions and type I cryoglobulinemia].
del Olmo J; España A; Idoate MA; Panizo C
Actas Dermosifiliogr; 2008 Mar; 99(2):138-44. PubMed ID: 18346436
[TBL] [Abstract][Full Text] [Related]
29. [Bing-Neel syndrome revealing Waldenström's macroglobulinemia].
Drouet T; Behin A; Psimaras D; Choquet S; Guillevin R; Hoang Xuan K
Rev Neurol (Paris); 2010 Jan; 166(1):66-75. PubMed ID: 19403149
[TBL] [Abstract][Full Text] [Related]
30. [Waldenström's macroglobulinemia with preserved antierythrocyte and antilipoprotein antibody activity].
Zittoun R; Beaumont JL; Homberg JC; Carbonniere C; Debre P; Bousser J
Sem Hop; 1975 Dec; 51(48):2943-8. PubMed ID: 175506
[TBL] [Abstract][Full Text] [Related]
31. [Waldenström's macroglobulinemia].
Brouet JC
Rev Prat; 2006 Jan; 56(1):25-30. PubMed ID: 16548246
[TBL] [Abstract][Full Text] [Related]
32. Waldenstrom macroglobulinemia presenting with pancreatic mass: a case report and review of literature.
Nayak HK; Kar P; Bagchi A; Kapoor N; Kapahtia S; Sonika U; Kumar N; Kumar S
JOP; 2013 Jan; 14(1):92-5. PubMed ID: 23306344
[TBL] [Abstract][Full Text] [Related]
33. [Effective treatment with rituximab in two patients with Waldenström macroglobulinemia].
Yoshimi A; Arai S; Iijima K; Iki S; Usuki K; Urabe A
Rinsho Ketsueki; 2005 Oct; 46(10):1109-13. PubMed ID: 16440772
[TBL] [Abstract][Full Text] [Related]
34. An unusual reoccurrence of Waldenstrom's macroglobulinemia as pleural effusions that had a discordant response with treatment.
Amin CJ; Rabinowitz I
Clin Lab Haematol; 2005 Jun; 27(3):200-2. PubMed ID: 15938727
[TBL] [Abstract][Full Text] [Related]
35. The clinical and cellular aspects of Waldenström's macroglobulinaemia.
Ricci C; Cascio G; Anania A; Marchi L; Verney MM
Arch Geschwulstforsch; 1988; 58(4):267-74. PubMed ID: 3138961
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal IgM with anti-muscle tissue activity in a patient with Waldenström's macroglobulinaemia: secretion of identical immunoglobulin by the established lymphoid cell line.
Micouin C; Seigneurin JM; Renversez JC; Roussel B; Favre M; Leroux D
Clin Exp Immunol; 1984 Dec; 58(3):677-84. PubMed ID: 6096055
[TBL] [Abstract][Full Text] [Related]
37. Crossreacting idiotypes of kappa-monoclonal immunoglobulins M in sera of patients with Waldenström's macroglobulinemia.
Wehmeier U; Rilke H; Patzold U; Schedel I; Deicher H
Immunobiology; 1987 Dec; 176(1-2):144-53. PubMed ID: 2834288
[TBL] [Abstract][Full Text] [Related]
38. Deposits of paraprotein in small vessels as a cause of skin ulcers in Waldenström's macroglobulinemia.
Wagner DR; Eckert F; Gresser U; Landthaler M; Middeke M; Zöllner N
Clin Investig; 1993 Dec; 72(1):46-9. PubMed ID: 8136617
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Owen RG; Treon SP; Al-Katib A; Fonseca R; Greipp PR; McMaster ML; Morra E; Pangalis GA; San Miguel JF; Branagan AR; Dimopoulos MA
Semin Oncol; 2003 Apr; 30(2):110-5. PubMed ID: 12720118
[TBL] [Abstract][Full Text] [Related]
40. [Sarcomatous and leukemic forms of Waldenström's macroglobulinemia].
Dao C; Zittoun R; Diebold J; Cadiou M; Reynes M; Gaudric M; Tricot G; Bousser J
Sem Hop; 1975 Dec; 51(48):2935-42. PubMed ID: 175505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
